Application of Nanotechnology in Drug Delivery Systems for Cancer Treatment

Thesis Abstract

Abstract
The application of nanotechnology in drug delivery systems has revolutionized cancer treatment by enhancing drug efficacy and reducing adverse effects. This thesis explores the potential of nanotechnology in improving cancer therapy through targeted drug delivery mechanisms. The study aims to investigate the utilization of nanocarriers for delivering anti-cancer drugs specifically to tumor sites, thereby enhancing therapeutic outcomes and minimizing systemic toxicity. The literature review provides a comprehensive analysis of existing research on nanotechnology-based drug delivery systems for cancer treatment, highlighting the advantages and challenges associated with this approach. Various types of nanocarriers, including liposomes, nanoparticles, dendrimers, and micelles, are examined in terms of their ability to encapsulate and deliver anti-cancer agents effectively. The research methodology section details the experimental design and methodologies employed to evaluate the performance of nanocarriers in delivering chemotherapeutic drugs to cancer cells. In vitro and in vivo studies are conducted to assess the efficacy, stability, and safety of the nanocarriers, as well as their ability to target and penetrate tumor cells. The findings from the study demonstrate the potential of nanotechnology-based drug delivery systems in improving the therapeutic efficacy of anti-cancer drugs while minimizing off-target effects. The discussion delves into the mechanisms of action of nanocarriers and their interactions with cancer cells, highlighting the importance of optimizing drug release kinetics and targeting specificity for enhanced treatment outcomes. In conclusion, the results of this study underscore the significant role of nanotechnology in advancing cancer therapy through the development of targeted drug delivery systems. The application of nanocarriers offers a promising strategy to overcome the limitations of conventional cancer treatments and improve patient outcomes. This research contributes valuable insights to the field of oncology and paves the way for the development of more effective and personalized cancer therapies.